BCR and chronic myelogenous leukemia, BCR-ABL1 positive: The unique cytogenetic features of CML include the Philadelphia chromosome t (9; 22) (q34; q11), forming a BCR-ABL fusion gene; this gene complex encodes a constitutively active form of the BCR–ABL fusion tyrosine kinase protein.